Skip to main content
. 2021 Nov 16;11:22365. doi: 10.1038/s41598-021-01530-w

Table 1.

Functional characterization of primary humanized 4A11 variants.

Variants Human germline acceptor framework TGFβ binding by Biacore SPR (KD: pM)d TGFβ inhibition by HEK-Blue cells (IC50: nM)e Blockingc
LC HC TGFb1 TGFb2 TGFb3 TGFb1 TGFb2 TGFb3
rbt4A11  > 5000a 1.6 1.2  > 667b 0.9 0.1 Complete
h4A11.v1 IGKV4-1*01 IGHV3-48*01  > 5000a 4.6 14.4  > 667b  > 667b  > 667b Incomplete
h4A11.v2 IGKV1D-39*01 IGHV3-48*01  > 5000a 1.4 13.3  > 667b  > 667b  > 667b Incomplete
h4A11.v3 IGKV4-1*01 IGHV4-59*06  > 5000a 9.6 12.1  > 667b 3.9 0.2 Complete
h4A11.v4 IGKV1D-39*01 IGHV4-59*06  > 5000a 10 10.1  > 667b 1.9 0.1 Complete
h4A11.v5 IGKV3-20*01 IGHV3-48*01  > 5000a 12.1 13.9  > 667b  > 667b  > 667b Incomplete
h4A11.v6 IGKV2-24*01 IGHV3-48*01  > 5000a 8.4 12.5  > 667b  > 667b  > 667b Incomplete
h4A11.v7 IGKV3-20*01 IGHV4-59*06  > 5000a 6.3 9.7  > 667b 0.9 0.2 Complete
h4A11.v8 IGKV2-24*01 IGHV4-59*06  > 5000a 8.2 14.1  > 667b 4.8 0.7 Complete

aThe binding was not observed at the highest TGFβ1 concentration (5 nM); therefore, the reported KD are lower limits.

bThe maximun inhibition did not achieve over 90% at the highest antibody concentration (667 nM); therefore, the reported IC50 are lower limits.

cThe complete blocking or incomplete blocking was defined by TGFβ2 and TGFβ3 inhibition greater than 90% or less than 70%, respectively, at the highest antibody concentration.

dThe affinity constant (KD) for each variant is calculated using a global fitting model and reported as a single value for the whole data set with an average fitting standard error of 10%.

eThe half-maximal inhibitory concentration (IC50) for each variant from quadruplicate experiments is calculated using nonlinear regression with a four-parameter variable slope curve fit and reported as a single value with an average fitting standard error of 10%.